-
1
-
-
0026422422
-
The use of intravenous immune globulin in immunodeficiency diseases
-
Buckley R, Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N Engl J Med 1991;325:110-7.
-
(1991)
N Engl J Med
, vol.325
, pp. 110-117
-
-
Buckley, R.1
Schiff, R.I.2
-
2
-
-
0028857579
-
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiency: Safety and costs
-
Gardulf A, Anderson V, Bjorkander J, Ericson D, Froland SS, Gustafson R, et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiency: safety and costs. Lancet 1995;345:365-9.
-
(1995)
Lancet
, vol.345
, pp. 365-369
-
-
Gardulf, A.1
Anderson, V.2
Bjorkander, J.3
Ericson, D.4
Froland, S.S.5
Gustafson, R.6
-
3
-
-
0032086995
-
Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: Use of an old method with a new product
-
Stiehm ER, Casillas AM, Finkelstein JZ, Gallagher KT, Groncy PM, Kobayashi RH, et al. Slow subcutaneous human intravenous immunoglobulin in the treatment of antibody immunodeficiency: use of an old method with a new product. J Allergy Clin Immunol 1998;101:848-9.
-
(1998)
J Allergy Clin Immunol
, vol.101
, pp. 848-849
-
-
Stiehm, E.R.1
Casillas, A.M.2
Finkelstein, J.Z.3
Gallagher, K.T.4
Groncy, P.M.5
Kobayashi, R.H.6
-
4
-
-
0000419304
-
Agammaglobulinemia
-
Bruton O. Agammaglobulinemia. Pediatrics 1952;9:722-8.
-
(1952)
Pediatrics
, vol.9
, pp. 722-728
-
-
Bruton, O.1
-
5
-
-
0028168260
-
Systemic and topical immunoglobulin treatments in immunocompromised patients
-
Hammarstrom L, Gardulf A, Hammarstrom V, Janson A, Lindberg K, Smith CIE. Systemic and topical immunoglobulin treatments in immunocompromised patients. Immunol Rev 1994;139:43-70.
-
(1994)
Immunol Rev
, vol.139
, pp. 43-70
-
-
Hammarstrom, L.1
Gardulf, A.2
Hammarstrom, V.3
Janson, A.4
Lindberg, K.5
Smith, C.I.E.6
-
6
-
-
0035176667
-
Replacement intravenous immune serum globulin therapy in patients with antibody immune deficiency
-
Thampakkul S, Ballow M. Replacement intravenous immune serum globulin therapy in patients with antibody immune deficiency. Immunol Allergy Clin North Am 2001;21:165.
-
(2001)
Immunol Allergy Clin North Am
, vol.21
, pp. 165
-
-
Thampakkul, S.1
Ballow, M.2
-
7
-
-
0030793979
-
Human intravenous immunoglobulin in primary and secondary antibody deficiencies
-
Stiehm ER. Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J 1997;16:696-707.
-
(1997)
Pediatr Infect Dis J
, vol.16
, pp. 696-707
-
-
Stiehm, E.R.1
-
8
-
-
0018825013
-
Immunoglobulin replacement therapy by slow subcutaneous infusion
-
Berger M, Cupps TR, Fauci AS. Immunoglobulin replacement therapy by slow subcutaneous infusion. Ann Intern Med 1980;93:55-66.
-
(1980)
Ann Intern Med
, vol.93
, pp. 55-66
-
-
Berger, M.1
Cupps, T.R.2
Fauci, A.S.3
-
9
-
-
0029908505
-
Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies
-
Abrahamsen TG, Sandersen H, Bustnes P. Home therapy with subcutaneous immunoglobulin infusions in children with congenital immunodeficiencies. Pediatrics 1996;98:1127-31.
-
(1996)
Pediatrics
, vol.98
, pp. 1127-1131
-
-
Abrahamsen, T.G.1
Sandersen, H.2
Bustnes, P.3
-
10
-
-
0035049375
-
Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women
-
Gardulf A, Andersson E, Lindqvist M, Hansen S, Gustafson R. Rapid subcutaneous IgG replacement therapy at home for pregnant immunodeficient women. J Clin Immunol 2001;21:150-4.
-
(2001)
J Clin Immunol
, vol.21
, pp. 150-154
-
-
Gardulf, A.1
Andersson, E.2
Lindqvist, M.3
Hansen, S.4
Gustafson, R.5
-
11
-
-
0031802363
-
Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy
-
Sundin U, Nava S, Hammarstrom L. Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy. Clin Exp Immunol 1998;112:341-6.
-
(1998)
Clin Exp Immunol
, vol.112
, pp. 341-346
-
-
Sundin, U.1
Nava, S.2
Hammarstrom, L.3
|